Tavo Biotherapeutics has raised $17 Million in new Series A funding
According to filings with the U.S. Securities and Exchange Commission, Tavo Biotherapeutics has raised $17 Million in new Series A funding. The federal securities law requires the notice to be filed by companies that have…